drugset / Trial / NCT00861536
Comparison of ATG to Thymoglobuline in Renal Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
An open, multicenter, randomised, parallel group pilot study to investigate two different polyclonal rabbit immunoglobulin preparations for safety and efficacy: A comparison of ATG-Fresenius S to Thymoglobulin in prophylaxis for immunological high risk patients following renal transplantation. This non-inferiority trial shall demonstrate that ATG-Fresenius S is as efficacious as Thymoglobulin but has a better tolerance and fewer side effects.
Timeline
- Start
- 2009-01
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thymoglobulin | Protein / enzyme biologic | 3 mg/kg | — |
| Comparator | Thymoglobuline Genzyme | Unknown | 1.5 mg/kg | — |
Indications
No indication recorded.